Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity
Background Lipid accumulation product (LAP) is associated with the presence and severity of nonalcoholic fatty liver disease (NAFLD) in adults. Purpose Here we evaluated the ability of LAP to predict NAFLD in obese children. Methods Eighty obese children (38 girls; age 6-18 years) were included. Ant...
Saved in:
Main Authors: | Bahar Özcabı (Author), Salih Demirhan (Author), Mesut Akyol (Author), Hatice Öztürkmen Akay (Author), Ayla Güven (Author) |
---|---|
Format: | Book |
Published: |
Korean Pediatric Society,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
by: Yuting Ma, et al.
Published: (2022) -
Nonalcoholic Fatty Liver Disease An Update
Published: (2019) -
Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023) -
Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019) -
Patophysiology of nonalcoholic fatty liver disease
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2019)